Q3 2020 Sesen Bio Inc Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Sesen Bio Third Quarter 2020 Business Update Conference Call. (Operator Instructions) I would now like to hand the conference over to your speaker today, Ms. Erin Clark. Thank you. Please go ahead, madam.
Thank you, and good morning, everyone. Welcome to our third quarter business update call. On today's call, we will discuss our operating results for the third quarter ending September 30, 2020, as well as an update on the progress of studies related to affecting analytical comparability between clinical batches of Vicinium and commercial material, which is a key component of completing module 3 and finalizing the BLA submission.
Joining me on today's call are Dr. Thomas Cannell, President and Chief Executive Officer; Dr. Chad Myskiw, Executive Director of Supply Chain; and Monica Forbes, our Chief Financial Officer.
Earlier this morning, we issued a press release outlining some of the highlights that will be
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

